p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Abstract

Metastatic progression is the major cause of death in osteosarcoma, the most common bone malignancy in children and young adults. However, prognostic biomarkers and efficacious targeted treatments for metastatic disease remain lacking. Using an immunoproteomic approach, we discovered that autoantibodies against the cell-cycle kinase inhibitor p27 (KIP1, CDKN1B) were elevated in plasma of high-risk osteosarcoma patients. Using a large cohort of serum samples from osteosarcoma patients (n = 233), we validated that a higher level of the p27 autoantibody significantly correlated with poor overall and event-free survival (P < 0.05). Immunohistochemical analysis also showed that p27 was mislocalized to the cytoplasm in the majority of osteosarcoma cases and in highly metastatic osteosarcoma cell lines. We demonstrated that ectopic expression of cytoplasmic p27 promoted migration and invasion of osteosarcoma cells, whereas shRNA-mediated gene silencing suppressed these effects. In addition, mutations at the p27 phosphorylation sites S10 or T198, but not T157, abolished the migratory and invasive phenotypes. Furthermore, the development of pulmonary metastases increased in mice injected with cells expressing cytoplasmic p27 compared with an empty vector control. Collectively, our findings support further investigation of p27 as a potential prognostic biomarker and therapeutic target in osteosarcoma cases exhibiting aberrant p27 subcellular localization. Cancer Res; 76(13); 4002-11. ©2016 AACR.

• Authors: Yiting Li, Manjula Nakka, Aaron J Kelly, Ching C Lau, Mark Krailo, Donald A Barkauskas, John M Hicks, Tsz-Kwong Man
• Journal: Cancer research (Cancer Res) Vol. 76 Issue 13 Pg. 4002-11 (07 01 2016) ISSN: 1538-7445 [Electronic] United States
• PMID: 27197201 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: ©2016 American Association for Cancer Research.

Chemical References

• Biomarkers, Tumor
• CDKN1B protein, human
• Cyclin-Dependent Kinase Inhibitor p27

Topics

• Animals
• Apoptosis
• Biomarkers, Tumor (metabolism)
• Bone Neoplasms (metabolism, pathology)
• Case-Control Studies
• Cell Movement
• Cell Proliferation
• Child
• Cohort Studies
• Cyclin-Dependent Kinase Inhibitor p27 (metabolism)
• Female
• Follow-Up Studies
• Humans
• Immunoenzyme Techniques
• Lung Neoplasms (metabolism, secondary)
• Male
• Mice
• Mice, Inbred NOD
• Mice, SCID
• Neoplasm Staging
• Osteosarcoma (metabolism, pathology)
• Prognosis
• Survival Rate
• Tumor Cells, Cultured
• Xenograft Model Antitumor Assays